← Back to Analyst Consensus 
LXRX Buy
LEXICON PHARMACEUTICALS, INC.
Current Price —
Implied Upside —
Analysts 12
30-Day Momentum
▲ 1 upgrades / ▼ 0 downgrades / 0 reiterations from 1 firms
Next Earnings
Nov 11, 2026 (15 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 28, 2026 | Cantor Fitzgerald | initiate | — → Overweight | — | 50% |
| May 11, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| Mar 23, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Mar 10, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| Mar 5, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Sep 2, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $4 | 44% |
| Aug 7, 2025 | Citigroup | maintain | Buy → Buy | $1.9 | 54% |
| Jun 24, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $4 | 44% |
| Mar 28, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $4 | 44% |
| Mar 7, 2025 | Piper Sandler | maintain | Overweight → Overweight | $6 | 54% |
| Mar 7, 2025 | Needham | reiterate | Hold → Hold | $0 | 50% |
| Mar 7, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $4 | 44% |
| Mar 4, 2025 | Leerink Partners | downgrade | Outperform → Market Perform | $1 | 51% |
| Mar 3, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $4 | 44% |
| Mar 3, 2025 | Needham | reiterate | Hold → Hold | $0 | 50% |
| Jan 29, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $4 | 44% |
| Jan 29, 2025 | Needham | reiterate | Hold → Hold | $0 | 50% |
| Dec 23, 2024 | Needham | reiterate | Hold → Hold | $0 | 50% |
| Nov 25, 2024 | Needham | reiterate | — → Hold | $0 | 50% |
| Nov 22, 2024 | Needham | reiterate | — → Hold | $0 | 50% |
| Nov 13, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $6 | 44% |
| Nov 13, 2024 | Needham | reiterate | — → Hold | $0 | 50% |
| Nov 5, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $6 | 44% |
| Nov 1, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $6 | 44% |
| Nov 1, 2024 | Needham | reiterate | — → Hold | $0 | 50% |
| Oct 30, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Oct 30, 2024 | Needham | reiterate | — → Hold | $0 | 50% |
| Oct 23, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Oct 17, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Oct 3, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Sep 27, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Sep 11, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Sep 3, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Aug 21, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Aug 13, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Aug 2, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Jul 16, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Jun 24, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Jun 21, 2024 | HC Wainwright & Co. | reiterate | — → Buy | $10 | 44% |
| Jun 17, 2024 | HC Wainwright & Co. | initiate | — → Buy | $10 | 44% |
| May 3, 2024 | Needham | reiterate | — → Hold | $0 | 50% |
| Apr 30, 2024 | Leerink Partners | initiate | — → Outperform | $5 | 51% |
| Apr 23, 2024 | Needham | reiterate | — → Hold | $0 | 50% |
| Apr 11, 2024 | Needham | reiterate | — → Hold | $0 | 50% |
| May 31, 2023 | Citigroup | maintain | Buy → Buy | $8 | 54% |
| May 30, 2023 | Needham | maintain | — → Hold | $0 | 50% |
| Mar 7, 2023 | Jefferies | initiate | — → Hold | $3 | 52% |
| Nov 22, 2022 | Citigroup | maintain | Buy → Buy | $6 | 54% |
| Aug 12, 2022 | Piper Sandler | initiate | — → Overweight | $10 | 54% |
| Jul 1, 2022 | Citigroup | maintain | — → Buy | $20 | 54% |
Price Target Trend
May 4, 2026 Oct 27, 2026
EPS Estimates
0y —
+1y —
+1q —
0q —
Cross-Platform Signals
No cross-platform signals in the last 90 days